http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020117151-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 2019-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c1c72a26d31c63580b2959eb9428aeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8772adbbe9fa39d5ee440f88b3f24043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1565717bed0432d27b8e4f446914df1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c67cc6c3aded41f52d3986b2fcde2da7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7da5d9e0e7da7dba2aa37680b9bc5a85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9fcb8cecbef06dc47cf1cbce0bd235
publicationDate 2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020117151-A3
titleOfInvention A combination comprising fingolimod and modafinil
abstract The present invention relates to a pharmaceutical combination comprising fingolimod or a pharmaceutically acceptable salt thereof and modafinil or a pharmaceutically acceptable salt thereof for use in the treatment of multiple sclerosis in human, preferably in the prevention or the treatment of fatigue symptom of multiple sclerosis disease.
priorityDate 2018-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011178062-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2609912-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018082814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017020885-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398832
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9690109

Total number of triples: 36.